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Identification of PSD-95 as a Regulator
of Dopamine-Mediated Synaptic
and Behavioral Plasticity
nomenon can be elicited by a variety of agents with
distinct profiles of molecular action and can be general-
ized across many drugs of abuse. Psychostimulants act
directly on monoamine systems; for example, cocaine
blocks the activity of transporters for dopamine (DA),
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limbic dopamine pathway (Woolverton and Johnson,
1992). However, sensitization to psychostimulants can
occur without increased dopamine release, as evidencedSummary
by similar sensitizing effects of direct DA agonists (Wise
and Leeb, 1993). Furthermore, behavioral supersensitiv-To identify the molecular mechanisms underlying psy-
ity can also be produced by DA receptor antagonistschostimulant-elicited plasticity in the brain reward
(Burt et al., 1977), by genetic or pharmacological deple-system, we undertook a phenotype-driven approach
tion of DA (Creese et al., 1977; Rubinstein et al., 1988;using genome-wide microarray profiling of striatal
Kim et al., 2000), or by chronic antidepressant treatmenttranscripts from three genetic and one pharmacologi-
(Spyraki and Fibiger, 1981; D’Aquila et al., 2000). En-cal mouse models of psychostimulant or dopamine
hanced sensitivity of postsynaptic dopamine receptorssupersensitivity. A small set of co-affected genes was
mediated by components of GPCR signaling (Gainetdi-identified. One of these genes encoding the synaptic
nov et al., 2003; Rahman et al., 2003) and adaptationsscaffolding protein PSD-95 is downregulated in the
of further downstream mechanisms related to transcrip-striatum of all three mutants and in chronically, but not
tion, intracellular signaling pathways, and neuronalacutely, cocaine-treated mice. At the synaptic level,
structures in the striatum are believed to be primarilyenhanced long-term potentiation (LTP) of the fronto-
responsible for these behavioral manifestations (re-cortico-accumbal glutamatergic synapses correlates
viewed in Berke and Hyman, 2000; Nestler, 2001). Molec-with PSD-95 reduction in every case. Finally, targeted
ular manipulation of some adaptations per se in rodentsdeletion of PSD-95 in an independent line of mice en-
effectively recapitulates or attenuates the behavioral re-hances LTP, augments the acute locomotor-stimulat-
sponses to drug challenges (Carlezon et al., 1998; Kelzing effects of cocaine, but leads to no further behav-
et al., 1999; Bibb et al., 2001), supporting the notion thatioral plasticity in response to chronic cocaine. Our
an enhancement in dopamine transmission is sufficientfindings uncover a previously unappreciated role of
but not necessary for drug-dependent psychomotor
PSD-95 in psychostimulant action and identify a mo-
plasticity. Finally, psychostimulant administration leads
lecular and cellular mechanism shared between drug- to long-lasting modifications of cortical glutamatergic
related plasticity and learning. efferent to the mesolimbic dopamine system, implicat-
ing glutamatergic mechanisms in the induction and
Introduction maintenance of behavioral sensitization (White et al.,
1995; Thomas et al., 2001; Ungless et al., 2001). While
Alterations of the brain reward system following chronic each of the above mechanisms may contribute to certain
exposure to addictive drugs underlie the neural mecha- aspects of behavioral supersensitivity, common under-
nisms related to addiction (Koob and Le Moal, 1997; lying molecular and cellular mechanisms may exist that
Berke and Hyman, 2000; Laakso et al., 2002; Wise, 2002). have yet to be identified.
A compelling model of behavioral plasticity thought to Several genetically engineered mice targeting mono-
underlie certain aspects of addiction is the progressive amine transporters, while differing in their monoamine
and enduring escalation in psychomotor responses fol- homeostasis and dynamics, all display heightened sen-
lowing repeated psychostimulant exposures, known as sitivity to either direct or indirect dopamine agonists
“behavioral sensitization” or “reverse tolerance” (Wool- (Figure 1B). Plasma membrane monoamine transporters
verton and Johnson, 1992; Robinson and Berridge, control the homeostasis and transmission of mono-
1993; White and Kalivas, 1998; Nestler, 2001). This phe- amines through recapturing the released neurotransmit-
ters, while vesicular monoamine transporters (VMAT)
load DA, NE, and 5-HT into synaptic vesicles (Amara and*Correspondence: caron002@mc.duke.edu
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Figure 1. Microarray Experiments
(A) Pharmacological model of sensitization.
C57BL/6J wild-type mice were injected daily
with cocaine (20 mg/kg, i.p.) or saline for 5 days.
Locomotor activity measurements were per-
formed on day 1 and day 7 (n 8–22 for each
group). Saline or cocaine challenges were
given at the 30 min mark. Note the signifi-
cantly enhanced locomotor responses to the
same dose of cocaine challenge on day 7
compared to day 1.
(B) Genetic models of behavioral supersensi-
tivity: summary of neurochemical and behav-
ioral pharmacological characteristics. See In-
troduction for details.
(C) Functional breakdown of microarray-iden-
tified genes in the striatum of three transgenic
mutants and cocaine-treated mice. Numbers
in parentheses represent the number of anno-
tated genes versus total number of genes.
The complete gene lists are shown in Supple-
mental Tables S1–S4 at http://www.neuron.
org/cgi/content/full/41/4/625/DC1.
(D) Venn diagram showing the overlapping
genes in the striatum of DAT/, NET/,
VMAT2/, and cocaine-treated mice. Num-
bers in the overlapping regions represent
commonly regulated genes.
(E) Relative expression levels of the six com-
monly affected genes identified in (C). Probe
set ID and gene descriptions are shown.
Kuhar, 1993). Targeted inactivation of the DA transporter Here we undertook a phenotype-driven, microarray-
(DAT/) leads to disrupted clearance of DA and 5-fold based genomic approach to search for the common
elevation in extracellular DA concentration (Giros et al., mechanisms underlying this form of behavioral plasticity
1996; Gainetdinov et al., 2002). Lack of the major target using DAT/, NET/, and VMAT2/ as well as mice
of psychostimulants in DAT/ prevents assessment of chronically treated with cocaine. We demonstrate a
locomotor-stimulating (Gainetdinov et al., 1999b), but concurrent diminution of PSD-95 and enhancement of
not rewarding (Rocha et al., 1998), effects of these drugs. nucleus accumbens LTP in both the genetically and
However, responses to direct DA agonists suggest that pharmacologically “sensitized” mice. Reciprocally, func-
despite marked downregulation of major DA receptor tional ablation of PSD-95 in mice enhances LTP, aug-
populations, some postsynaptic responses are in fact ments the stimulating effects of acute cocaine, and pre-
increased (Gainetdinov et al., 1999a). NE transporter vents any further increase in locomotor response to
knockouts (NET/) demonstrate prolonged synaptic NE cocaine following repeated administration. Our data
clearance and elevated extracellular NE but diminished identify a molecular and cellular mechanism common
Striatal DA concentration, presumably underlying the to several forms of behavioral supersensitivity and illus-
postsynaptic D2/D3 DA receptor supersensitivity ob- trate a novel paradigm by which drugs of abuse can
served in these mice (Xu et al., 2000). While VMAT2/ usurp the reward circuits through altering the PSD-95-
mice die shortly after birth, VMAT2/ mice show dimin- mediated glutamatergic synaptic plasticity.
ished extracellular DA levels and release and display
enhanced sensitivity to direct and indirect DA receptor
Resultsagonists as well as ethanol (Wang et al., 1997). These
mice, along with normal mice treated with repeated in-
Microarray Screen for Commonly Affectedtermittent psychostimulants (Figure 1A), offer an excel-
Striatal Geneslent set of genetic and pharmacological models to ex-
To obtain striatal gene expression profiles for each strainplore the general mechanisms underlying core features
of behavioral plasticity elicited by psychostimulants. of mice in a uniform genetic background, we back-
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crossed each strain of mutants for at least 10 genera- posin, downregulated), as well as a protein of unknown
tions to derive DAT/, NET/, and VMAT2/ on a pure function (RIKEN 1200007D18, downregulated).
C57BL/6J background. This strategy would minimize We pursued PSD-95 for further investigation for the
the influence of genetic background on gene expression following reasons. First, PSD-95 plays an indispensable
(Sandberg et al., 2000). To derive an expression profile role in learning (Migaud et al., 1998), a process proposed
that emphasizes the lasting effect of chronic cocaine to share similarities with the molecular mechanisms un-
administration, we treated C57BL/6J wild-type mice derlying reward and addiction (Berke and Hyman, 2000;
with cocaine (20 mg/kg/day, i.p.) for 5 consecutive days Nestler, 2001; Schultz, 2002). Second, PSD-95 is an
and allowed a 14-day withdrawal period from the drug abundant postsynaptic density protein (Cho et al., 1992)
before microarray analyses. This standard protocol (Wang at glutamatergic synapses, regulating the maturation
et al., 1997; Xu et al., 2000; Gainetdinov et al., 2003) (El-Husseini et al., 2000) and strength (Migaud et al.,
produces robust behavioral sensitization that lasts for 1998; Beique and Andrade, 2003; Stein et al., 2003) of the
weeks. Striatal mRNA was harvested from the five con- excitatory synapses. The cortical glutamatergic system
genic mouse strains, biotinylated cRNA prepared, and has been implicated in behavioral sensitization (Wolf,
Affymetrix mouse GeneChips representing 36,000 1998; Thomas et al., 2001; Vanderschuren and Kalivas,
gene clusters (MG_U74v2 Set) used to probe the labeled 2000). Third, as a scaffolding protein of the membrane-
cRNA. Three independent RNA samples, each pooled associated MAGUK protein family, PSD-95 contains dis-
from five mice, were prepared for each condition. crete protein-protein interaction domains, including three
We used a pair-wise comparison algorithm to identify PDZ domains, an SH3 domain, and a guanylate kinase
candidate genes that exhibit altered expression in the (GK) homology domain (Garner and Kindler, 1996) that
striatum of DAT/, NET/, VMAT2/, and cocaine- participate in interactions with NMDA receptors, ion
treated mice relative to saline-treated wild-type con- channels, and signal transduction molecules, thus or-
trols. This strategy recognizes genes that show highly ganizing an intricate protein network into the postsynap-
consistent changes at the probe level and at least 20% tic density of excitatory synapses (Sheng and Kim,
change in overall expression levels (see Supplemental 2002). We reasoned that dysregulation of PSD-95 may
Experimental Procedures at http://www.neuron.org/cgi/ alter the signaling profiles of many pathways in the syn-
content/full/41/4/625/DC1). We identified 116, 273, 149, apse, ultimately leading to altered plasticity in neural
and 27 transcripts in DAT/, NET/, VMAT2/, and circuits critical for reward.
cocaine-treated mice, respectively (Figure 1C). We clus-
tered the annotated genes into groups by biological Reduction of PSD-95 Transcripts and Proteins:
function (Figure 1C and Supplemental Tables S1–S4). Generality and Specificity
Expectedly, the majority of affected genes encode pro- We validated the microarray results with two traditional
teins involved in mechanisms of signaling, transport, methods. In situ hybridization using a PSD-95-specific
transcription, ion channels and receptors, neural trans- probe reveals significant downregulation of PSD-95 in
mission, and cytoskeleton (Figure 1C). These genes ac- both the nucleus accumbens and the caudate putamen
count for 61.3%, 65.9%, 69.0%, and 73.3% of the total
of DAT/, NET/, VMAT2/, and chronic cocaine-
numbers of annotated genes affected in DAT/, NET/,
treated mice (20 mg/kg/day, 5 days, i.p., 14-day with-
VMAT2/, and cocaine-treated mice, respectively.
drawal; Figures 2A and 2B). Using the more quantitative
We focused our analyses on overlapping genes. Over-
and accurate real-time RT-PCR assay, we found that
all, 44.8%, 25.6%, and 40.3% of genes that exhibit al-
the amount of PSD-95 mRNA was reduced to 65.7% tered expression in DAT/, NET/, and VMAT2/ mice
4.7%, 47.6% 2.7%, 52.0% 7.0%, and 58.3% 6.2%are also affected in at least one other mutant strain,
in the striatum of DAT/, NET/, VMAT2/, and chronicrespectively (Figure 1D). Twenty-six transcripts are al-
cocaine-treated mice, respectively (Figure 2C).tered in all three knockouts, six of which are also simi-
We then examined PSD-95 protein using Western blotlarly altered in chronically cocaine treated mice, ac-
analysis. As shown in Figures 2D and 2F, total striatalcounting for 22% of the 27 genes in this group (Figures
PSD-95 proteins were diminished to 44.6%, 67.3%, and1D and 1E, Table 1). Three of the six genes encode,
55.7% in DAT/, NET/, and VMAT2/ mice, respec-respectively, adenylate cyclase 1 (upregulated), a key
tively, in comparison to wild-type littermates. Consis-component in the cAMP signaling pathway; Pin/Dlc-2
tently, repeated cocaine administration induced a simi-(protein inhibitor of neuronal nitric oxide synthase/
lar reduction (51.3% 8.3%, p 0.05) in striatal PSD-95dynein light chain-2, downregulated), a cytoskeletal pro-
protein levels (Figures 2E and 2F). The decrease of PSD-tein that may participate in scaffolding in inhibitory syn-
95 was not confined to either the caudate putamen or theapses (Fuhrmann et al., 2002); and PSD-95 (downregu-
nucleus accumbens of the striatum, as PSD-95 proteinlated), a postsynaptic scaffolding protein at excitatory
levels were diminished in both the dorsal and ventralglutamatergic synapses. The potential contribution of
structures (Figure 2D). Despite functional differences,cAMP-dependent pathways and NO signaling to reward,
both structures receive extensive, converging dopamineaddiction, and behavioral sensitization has been docu-
innervation from midbrain dopaminergic projections andmented previously (summarized in Table 1), immediately
glutamatergic input from the cortex.validating our approach and results. More remarkably,
The reduction in PSD-95 levels in the striatum couldcAMP and nitric oxide (NO) signaling and PSD-95 are
reflect an overall loss of glutamatergic synapses in thisall implicated in experience-dependent plasticity, such
brain region. To evaluate this possibility, we analyzedas learning and memory (Table 1). The remaining three
the protein levels of several established presynaptic andgenes encode, respectively, a postsynaptic calcium-
postsynaptic markers (Figure 3). The amounts of synap-sensing membrane protein (calsyntenin 1, upregulated),
a neurotrophic and myelinotrophic glycoprotein (prosa- sin (a synaptic vesicle protein), syntaxin (a presynaptic
Neuron
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Table 1. Genes Commonly Affected in the Striatum of DAT/, NET/, VMAT2/, and Chronic Cocaine-Treated Mice Identified by Microarrays
GenBank ID Description Map Location Changes Cellular Function Behavioral Associations
AW123151 Adenylate cyclase 1 11 A2 up signal transduction, learning and memory,a
synaptic plasticity addiction,b pain processingc
D50621 PSD-95 11 B4 down synaptic plasticity, learning,d pain processinge
scaffolding
AW047674 Pin/Dlc-2 11 C down NOS activity/NO signaling, learning and memory,f,g
microtubule-based addiction,f,h responses to
process psychostimulants,f,i
behavioral sensitizationf,i
AW048171 Calsyntenin 1 4 up Ca2-dependent process unknown
AF037437 Prosaposin 10 down neurotrophic factor, Gaucher’s disease j
sphingolipids degradation
AA815795 RIKEN 1200007D18 17 A3.3 down unknown unknown
Map location: chromosome and position mapped with NetAffx (http://www.Affymetrix.com).
a Livingston et al., 1984; Wong et al., 1999
b Moore et al., 1998; Berke and Hyman, 2000; Nestler, 2001
c Wei et al., 2002
d Migaud et al., 1998
e Garry et al., 2003
f Based on modulation of NOS activity and NO signaling.
g Prast and Philippu, 2001
h Collins and Kantak, 2001; Gholami et al., 2002
i Wolf, 1998
j O’Brien and Kishimoto, 1991
plasma membrane protein), and NF-H (neurofilament tein levels were also significantly decreased specifically
in the striatum, but not in the cortex and hippocampus,heavy chain subunit, an axonal marker) did not differ
of cocaine-treated animals (Figure 4A).between wild-type controls and any of the “genetically”
We next determined the number of cocaine injectionsor pharmacologically sensitized mice (Figure 3A), sug-
needed to establish the sustained decline in PSD-95.gesting that the presynaptic structures are largely intact
Mice were given increasing number of cocaine injectionsin the striatum of these mice. Similarly, postsynaptic
and were analyzed for PSD-95 levels 14 days after theproteins, represented by three PSD-95 homologs in
last injection. One or two injections of cocaine at 20 mg/the MAGUK family that includes chapsyn-110/PSD-93,
kg/day did not induce noticeable changes in PSD-95SAP97, and SAP102 (Garner and Kindler, 1996) did not
proteins (Figure 4B). In contrast, mice receiving threeshow discernable differences. Another postsynaptic
or more injections exhibited substantial decreases inprotein, MAP-2 (microtubule-associated protein-2, a
PSD-95 protein levels compared to saline-treated con-dendritic marker) did not differ in the genetically modi-
trols. Interestingly, ten consecutive cocaine injectionsfied mice, but exhibited a nearly 2-fold increase in mice
did not suppress PSD-95 protein levels more than fewerchronically treated with cocaine. This cocaine-induced
treatments (Figure 4B). Considering that mice receivingincrease in a dendritic structural protein is consistent
three or more cocaine injections developed sustainedwith the increased spine densities and sizes following
enhancement of responsiveness to cocaine (data notrepeated cocaine administration (Robinson and Kolb,
shown), these data suggest that striatal PSD-95 alter-1999). Consequently, the spines in the drug-treated
ations might be correlated with the behavioral plasticitygroup may be inevitably less enriched in PSD-95, which
elicited by chronic, but not acute, cocaine adminis-is expected to favor the formation of silent synapses
tration.(Stein et al., 2003). Together, our data suggest a selec-
One key characteristic of behavioral plasticity associ-tive decrease of a specific scaffolding protein, rather
ated with repeated psychostimulant administration is itsthan a global loss of synapses, in the striatum of several
extremely long-lived nature. While considerable effortsbehaviorally sensitized mouse strains.
have been made to identify the molecular mechanisms
that contribute to the persistent neural and behavioral
Effects of Chronic Cocaine on PSD-95: Spatial plasticity, specific changes identified so far are not suffi-
and Temporal Characteristics ciently long lasting to account for the nearly permanent
In addition to the striatum, the cortex and hippocampus behavioral modification (Nestler, 2001). We thus ex-
are also key components of the reward circuits and are plored the candidacy of PSD-95 downregulation as a
involved in drug-dependent behavioral plasticity (Berke mechanism underlying this phenomenon. Striatal PSD-
and Hyman, 2000; Wise, 2002). We asked whether co- 95 levels were measured at different time of withdrawal
caine elicits PSD-95 dysregulation in these regions. following the standard 5 day sensitization paradigm in
PSD-95 transcripts were selectively decreased in the wild-type mice. The PSD-95 protein levels were signifi-
striatum of chronic cocaine-treated mice, including the cantly lower the next day (53% 6%, p 0.01) following
nucleus accumbens and the caudate putamen, but were the last injection and continued to be significantly lower
statistically unchanged in the cortex and hippocampus than saline-treated controls at 10–14 days and 28–35
days after the last cocaine dose (Figure 4C). Remark-(Figure 2A and data not shown). Similarly, PSD-95 pro-
Forward-Genetic Approach to Behavioral Plasticity
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Figure 2. Assessment of mRNA and Protein
Levels of PSD-95 in the Striatum of DAT/,
NET/, VMAT2/, and Chronic Cocaine-
Treated Mice
(A) In situ hybridization analysis of PSD-95
mRNA. Bright-field images of representative
whole-brain sagittal sections are shown in
which mRNA signals are in black.
(B) Quantification of mRNA signals of in situ
hybridization reveals significant reduction of
PSD-95 mRNA in the nucleus accumbens and
caudate putamen in transgenic mutants (n 
4–5) and chronic cocaine-treated mice (n 
3) relative to saline-treated wild-type controls
(n  7).
(C) Real-time RT-PCR (Taqman) analysis of
PSD-95 mRNA. Significant reduction of PSD-
95 mRNAs was found in the whole striatum
of transgenic mutants and chronic cocaine-
treated mice relative to saline-treated con-
trols (n  5–10 mice for each group).
(D) Western blot analysis of extracts prepared
from the whole striatum, caudate putamen,
and nucleus accumbens shows lower amounts
of PSD-95 proteins in transgenic mutants (n 
8–12) compared to wild-type controls (n 
10–14).
(E) Western blots show decreased striatal
PSD-95 levels in cocaine-treated animals (n
7) in comparison to saline controls (n  8).
(F) Densitometric quantification of Western
blots.
Except when specified otherwise, C57BL/6J
males were treated with cocaine (20 mg/kg,
i.p.) or saline for 5 consecutive days and brain
mRNA and protein were analyzed 14 days
after discontinuing cocaine treatments. *p 
0.05, **p  0.01, ***p  0.001; two-tail Stu-
dent’s t tests against wild-type controls.
ably, the PSD-95 levels remained at 66.7% 2.7% (p of changes in residual Ca2dynamics and release proba-
bility, a form of short-term presynaptic plasticity. LTP0.05) of the control levels even 2 months after the cessa-
reflects a persistent enhancement in synaptic strength intion of cocaine administration, without returning to nor-
which both presynaptic and postsynaptic mechanismsmal levels (Figure 4C). Thus, modulation of PSD-95 at
might be involved (Bekkers and Stevens, 1990; Malenkaexcitatory synapses could represent a long-lasting mo-
and Nicoll, 1999).lecular adaptation that may contribute to the altered
The paired-pulse ratio did not differ at interpulse inter-responsiveness to psychostimulants.
vals of 20, 50, and 100 ms between DAT/, NET/, and
VMAT2/ mice and wild-type controls (Figure 5A), nor
Altered Cortico-Accumbal Glutamatergic between cocaine- and saline-treated wild-type mice
Synaptic Plasticity Associated with (Figure 5B), suggesting no gross changes in presynaptic
PSD-95 Reduction function in both the genetically and pharmacologically
We investigated whether the decreases in striatal PSD- sensitized mice. In contrast, LTP, induced by a minimal
95 levels in the “genetically” and pharmacologically sen- tetanus protocol (1 s, 100 Hz), was substantially en-
sitized mice translate to modification of synaptic plas- hanced in slices prepared from DAT/, NET/, and
ticity. The excitatory cortico-accumbal glutamatergic VMAT2/ mice relative to their wild-type littermates
pathway has been implicated in the expression of drug- (Figures 5C and 5D). Furthermore, LTP was also larger
induced sensitization (White et al., 1995; Wolf, 1998; in slices from the cocaine group compared to the saline
Vanderschuren and Kalivas, 2000; Thomas et al., 2001) controls (Figures 5E and 5F). It is interesting to note,
in particular and aberrant rewarding processes (Robbins however, that while the posttetanic potentiation at both
and Everitt, 2002; Schultz, 2002) in general. We exam- the early (immediately following tetanus) and the late
ined two parameters of synaptic plasticity of this path- (30 min posttetanus) time course are enhanced in the
way in adult mice: paired-pulse facilitation (PPF) and three mutants, only the late LTP is significantly en-
hanced by cocaine exposure (Figure 5F), suggestinglong-term potentiation (LTP). PPF is a sensitive measure
Neuron
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receptor complex (PSD-93 and SAP102) (Figure 6C) as
well as NMDA receptor subunits (data not shown) were
unaltered in the mutant mice. When compared to their
wild-type littermates, PSD-95-GK mice showed no dif-
ference in PPF (Figure 6D) but demonstrated striking
enhancements in tetanus-induced cortico-accumbal LTP
throughout the posttetanic recording session (Figure
6E). Importantly, the complete deletion of PSD-95 in the
mutant mice did not result in more LTP enhancements
than those observed for DAT/, NET/, VMAT2/, and
cocaine-treated mice at 30 min posttetanus (Figure 6F;
means  SEMs are 133.0%  5.0%, 222.0%  28.5%,
188.6%  13.7%, 201.0%  37.1%, 155.8%  11.8%,
and 175.4%  18.5% for control, DAT/, NET/,
VMAT2/, cocaine-treated, and PSD-95-GK mice, re-
spectively). Thus, much like removing functional PSD-
95 enhances LTP in the hippocampus (Migaud et al.,
1998), decreasing the level of PSD-95 in the striatum may
also account for the enhanced cortico-accumbal LTP.
Role of PSD-95 in Responsiveness to
Psychostimulants and Drug-Dependent
Behavioral Plasticity
We extended our molecular and electrophysiological
studies to behavioral and pharmacological analysis of
PSD-95-GK mice to investigate whether and how PSD-
95 regulates the acute and chronic responsiveness to
cocaine. In open field locomotor activity assays, unchal-
lenged PSD-95-GK were hypoactive, displaying signifi-
cantly lower horizontal (Figure 7A) and vertical (data not
shown) activities and stereotypy (Figure 7B) than wild-
type littermates. However, acute administration of co-
caine elicited a significantly higher behavioral response
in PSD-95-GK mice than the wild-type littermates at all
doses tested (Figures 7C and 7D). The mutant mice
exhibited a significantly higher locomotor activation, as
measured by horizontal activity in response to 5 and 10
mg/kg cocaine than did wild-type littermates (Figure
7C). Cocaine at 20 mg/kg induced a horizontal activity
that was similar to that of the wild-type response. How-
Figure 3. Western Blot Analysis of Presynaptic and Postsynaptic ever, this dose elicited significantly increased stereo-
Protein Markers
typy, characterized by intensive sniffing, rearing, groom-
(A) Western blot analysis of selected presynaptic marker proteins
ing, licking, and paw chewing in PSD-95-GK mice inshows no differences among transgenic mutants, chronic cocaine-
comparison to wild-type littermates (Figure 7D). Stereo-treated mice, and wild-type controls.
typy has been shown to compete with and antagonize(B) Western blot analysis of selected postsynaptic proteins shows
no differences among transgenic mutants, chronic cocaine-treated locomotor activities at higher concentrations of psycho-
mice, and wild-type controls. One exception is MAP-2, which is stimulants and is an indication of higher degree of drug
increased by nearly 2-fold following repeated cocaine adminis- sensitivity. These data show that PSD-95 null mice are
tration.
supersensitive to cocaine, indicating that selective re-
duction of PSD-95 levels at glutamatergic synapses is
sufficient to confer the enhanced stimulating action ofthat the genetic models may not completely recapitulate
the synaptic alterations caused by repeated cocaine ad- cocaine, mediated predominantly by monoamine systems.
To explore the role of the glutamatergic PSD-95 inministration.
To further explore whether the enhanced LTP is due behavioral sensitization, we examined the locomotor re-
sponses before and after a standard sensitization regi-to a reduction in PSD-95 levels, we studied the PPF and
LTP in this cortical pathway in a genetically engineered men that consists of five consecutive daily cocaine ad-
ministration (Figure 8A). As shown in Figure 8, themouse line (PSD-95-GK) in which the GK domain of the
PSD-95 gene is deleted (Figure 6). Mice carrying the chronic cocaine-induced behavioral plasticity is absent
in PSD-95-GK mutants. Compared to the drug challengetruncated form of PSD-95 gene (Figure 6A) do not pro-
duce any detectable PSD-95 proteins in the striatum, prior to the treatment regimen, wild-type animals exhib-
ited enhanced locomotor responses to cocaine on dayas revealed by two independent antibodies recognizing
different protein sequences of PSD-95 (Figures 6B and 7, indicative of the development of sensitization. In con-
trast, PSD-95 mutants displayed nearly identical loco-6C). The levels of other MAGUK proteins in the NMDA
Forward-Genetic Approach to Behavioral Plasticity
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Figure 4. Spatial and Temporal Characteris-
tics of Striatal PSD-95 Following Repeated
Cocaine Administration
(A) PSD-95 protein levels were reduced in the
striatum, but not in the cerebral cortex and
hippocampus following 5-day cocaine ad-
ministration and 14-day withdrawal (n  5–9
mice for each group).
(B) Effects of increasing amount of cocaine
exposures on PSD-95 levels in the striatum.
Mice that received consecutive daily cocaine
injections over 3, 4, 5, or 10 days demon-
strated significantly lower levels of PSD-95
proteins in their striatum 10–14 days following
the last injection when compared to saline
controls. In contrast, PSD-95 levels were un-
altered in the striatum of mice that received
one or two cocaine doses.
(C) Long-lasting reduction in PSD-95 levels
following cessation of chronic cocaine expo-
sure. Mice were given daily cocaine for 5 days
and allowed for various periods of with-
drawal. The decrease of PSD-95 levels was
evident 1 day, 10–14 days (pooled), 28–35
days (pooled), and persisted for at least 2
months following the cessation of the last co-
caine dose (n  4–8 saline- or cocaine-
treated mice for each data point).
All results shown were from analyses of West-
ern blots. Insets in (B) and (C) are treatment
and analysis protocols.
motor responses to the same cocaine challenges before et al., 2002; Whitfield et al., 2003). This approach is even
and after the sensitization protocol (Figures 8B and 8C). more amenable to the comparison of multiple samples
Thus, while supersensitive to the acute stimulating ef- with identical or different phenotypes. In such studies
fect of cocaine, PSD-95-GK mice showed no evidence with mouse CNS tissue, it would seem that starting with
for further sensitization under this sensitization routine. a homogeneous genetic background and multiple repli-
The requirement of PSD-95 for the full expression of cates would be essential to assure quality and reliability
behavioral sensitization suggests that intact PSD-95- of the microarray data. In this study, all mice used for
mediated mechanisms at glutamatergic synapses are microarray analysis were C57BL/6J congenic mice and
an integral component of drug-dependent, monoamine- all experiments were repeated three times using inde-
mediated behavioral plasticity. pendent samples. In addition, indirect validation of the
observations presented here came from the fact that
numerous genes previously implicated in psychostimu-Discussion
lant-induced striatal neuroadaptations are contained in
our data set (see Supplemental Tables S1–S4 at http://Striatal Transcript Profiles Associated
www.neuron.org/cgi/content/full/41/4/625/DC1). Ex-with Monoamine Dysfunction
amples include, but are not limited to, transcripts forGenome-wide expression profiling provides a powerful
cholecystokinin (Beinfeld et al., 2002), prodynorphinunbiased approach to identify putative molecular and
(Daunais and McGinty, 1994), brain-derived neuro-cellular changes that may underlie phenotypic proper-
ties of a cell or an organism (Mirnics et al., 2000; McGill trophic factor (Grimm et al., 2003), per1 and per2 (Abarca
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Figure 5. Altered Synaptic Plasticity in the
Nucleus Accumbens in DAT/, NET/,
VMAT2/, and Chronic Cocaine-Treated Mice
(A and B) Paired-pulse facilitation is normal.
PPF was measured with pairs of presynaptic
cortical stimulation pulses at intervals of 20,
50, and 100 ms. A representative recording
from a wild-type slice is shown as inset. n 
6–16 slices from 4–7 mice for each data point.
(C and D) Enhanced LTP in DAT/, NET/,
and VMAT2/ mice. LTP was induced by a
high-frequency tetanus (100 Hz, 1 s) delivered
at the 10 min mark. Representative traces
during baseline recordings (black) and 30 min
after the tetanus (red) are shown for each
strain of mice (C) and summary graph is
shown in (D). Data are from five DAT/ slices
(n  5 mice), six NET/ slices (n  4 mice),
seven VMAT2/ slices (n  6 mice), and ten
wild-type slices (n  7 mice), all on C57BL/
6J background.
(E and F) Enhanced LTP in chronic cocaine-
treated mice. Sample recordings are shown
in (E) and summary graph for 7 saline slices
and 9 cocaine slices are shown in (F). Adult
C57BL/6J wild-type mice were treated with
either cocaine (n 5) (20 mg/kg, i.p.) or saline
(n 5) for 5 consecutive days and were used
for recordings 2–3 days following the last in-
jection.
et al., 2002), synaptotagmin IV (Yuferov et al., 2003), S4 at http://www.neuron.org/cgi/content/full/41/4/625/
DC1). Second, there are substantial overlaps of affectedand Fos-like antigen 2 (Hope et al., 1994), as well as
components of the MAPK, PKA, and CaMKII pathways. genes between different lines of mutants (Figure 1D),
supporting our hypothesis that common molecular ad-Further internal validation of the data set is the observa-
tion that different probe sets against the same gene clus- aptations may occur in these mutants despite distinct
lesions in their monoamine systems. Third, in severalters often produced the similar transcriptional changes
(Supplemental Tables S1–S4). Finally, McClung and instances, different members of the same gene family
are affected in different mutants, suggesting an overlapNestler (2003) recently reported microarray analyses of
theFosB- and CREB-regulated genes using two induc- at the functional level. For example, the gene encoding
the voltage-dependent calcium channel  2/delta sub-ible mouse models of cocaine reward. Interestingly,
there is a striking overlap between the genes induced unit 2 is upregulated in DAT/, whereas the  1A subunit
of P/Q type is upregulated in both NET/ and VMAT2/by FosB and CREB overexpression and the genes al-
tered by monoamine dysregulation in our study. mice. Furthermore, more than one member of the same
gene families is often altered in a mutant.Our data reveals interesting features about the tran-
scriptional profiles related to dysregulation of mono- Five of the six genes commonly affected in the three
mutants as well as cocaine-treated mice all encode syn-amine homeostasis and dynamics. First, among many
biological processes defined by the Gene Ontology Con- aptic or neuronal proteins. The subcellular localization,
molecular function, and interacting partners of thesesortium (http://www.geneontology.org), we found that
alterations of monoamine homeostasis and signaling proteins predict a high likelihood that they may play a
role in neural development and/or plasticity. Adenylateprimarily affect a relatively restricted subset of pro-
cesses, namely intracellular or transmembrane signal cyclases are best known for their potential contributions
to learning and memory (Livingstone et al., 1984; Wongtransduction, transport, transcriptional regulation, ion
channels, receptors and transporters, neurotransmitters et al., 1999), ethanol intoxication (Moore et al., 1998),
pain processing (Wei et al., 2002), and addiction. Upreg-and synaptic transmission, as well as cytoskeletal re-
arrangement (Figure 1C and Supplemental Tables S1– ulation of the cAMP pathway is arguably the best-estab-
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Figure 6. Assessment of Synaptic Plasticity
in the Nucleus Accumbens of PSD-95 Null
Mice
(A) The PSD-95-GK mice. A schematic dia-
gram illustrating the targeted deletion of the
GK domain of the PSD-95 gene in the mu-
tant mice.
(B and C) Absence of striatal PSD-95 proteins
in PSD-95-GK mice. Western blot analyses of
striatal extracts using two antibodies against
different regions of PSD-95 show that PSD-
95-GK mutant mice do not produce any de-
tectable PSD-95 proteins. Immunogen a rec-
ognizes the amino acid residues 77–299 at
the N terminus; immunogen b recognizes the
amino acid residues 353–504 within the PDZ3
domain. PSD-93 and SAP102 are not affected
in the mutant mice.
(D) Paired-pulse facilitation is not affected in
PSD-95-GK mice. n  9–12 slices from 4–5
mice for each data point.
(E) Cortical-accumbal LTP is enhanced in
PSD-95-GK mice. Mean  SEM are pre-
sented for five PSD-95-GK slices (n 4 mice)
and four slices from the wild-type littermates
(n  4 mice).
(F) Summary of LTP data. LTP was measured
at 30 min posttetanus and presented as
mean  SEM. Wild-type data used in this
graph were combinations of C57BL/6J WT
(Figure 5D) and PSD-95-WT mice (E). *p 
0.05, **p  0.01; two-tail Student’s t tests
against wild-type.
lished adaptation to drugs of abuse such as morphine tant roles in drug responses and plasticity. Pharmaco-
logical inhibition of neuronal NO synthase has been(Berke and Hyman, 2000; Nestler, 2001). The common
increase of adenylate cyclase 1 expression in DAT/, shown to attenuate sensitization to cocaine and several
drugs of abuse (reviewed in Wolf, 1998), as well as co-NET/, VMAT2/, and cocaine-treated mice is in line
with this theme. Pin/Dlc-2, a close homolog of the origi- caine self-administration (Collins and Kantak, 2002) and
morphine-induced place preference (Gholami et al.,nal protein inhibitor of neuronal nitric oxide synthase
(Pin or Dlc-1; Jaffrey and Snyder, 1996) may play impor- 2002). In our microarray analysis, striatal Pin/Dlc-2 is
Figure 7. Enhanced Acute Responses to Co-
caine in PSD-95-GK Mutants
(A and B) Locomotor activity in the open field
of wild-type (n  6) and PSD-95-GK (n  8)
mice. While habituating to a similar degree,
both the horizontal activity (A) and stereotypy
time (B) were lower in PSD-95-GK compared
to wild-type mice.
(C) Locomotor responses to different concen-
trations of cocaine stimulation. Although less
active before drug challenges, PSD-95-GK
mice (n  7–8) displayed significantly higher
horizontal locomotor activities in response to
5 mg/kg and 10 mg/kg cocaine than did wild-
type littermates (n  6). Cocaine at 20 mg/kg
elicited only slightly higher locomotor re-
sponses in PSD-95-GK (n  10) mice when
compared to wild-type mice (n  9).
(D) Increased stereotypy in PSD-95-GK mice
(n  8), measured 60 min postinjection, in
response to different concentrations of co-
caine, compared to wild-type littermates
(n  6).
*p  0.05; two-tail Student’s t tests against
wild-type littermates.
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Figure 8. Absence of Cocaine-Induced Be-
havioral Plasticity in PSD-95-GK Mutants
(A) Sensitization regimen. Mice were first
tested for their locomotor sensitivity to 10 mg/
kg or 5 mg/kg cocaine on day 0. Mice were
then injected daily with cocaine (20 mg/kg, i.p.)
for 5 days. Mice were challenged on day 7
with 10 mg/kg or 5 mg/kg cocaine for the
development of behavioral sensitization.
(B) Locomotor response of PSD-95-GK (n 
10) and wild-type (n  7) littermates to co-
caine administration (10 mg/kg, i.p., injected
at 0 min) before and after the sensitization
protocol. Wild-type mice displayed substan-
tial potentiation in their response to the same
test dose of cocaine following a sensitization
regimen, while the PSD-95 mutants did not.
(C) Accumulated horizontal activity after co-
caine administration (5 or 10 mg/kg, i.p.) on
days 0 or 7 over a 40 min period (between 10
and 50 min postinjection), during which mice
are fully activated (n  7–11 mice in each
group). Significance assessed by two-tail
Student’s t tests.
downregulated in every mutant and following cocaine transcriptional alterations in chronic cocaine-treated
mice suggest that the robust behavioral plasticity inexposure, which in principle may promote the expres-
sion of sensitization. Lastly, although the exact contrib- these animals may primarily depend on posttranscrip-
tional mechanisms and modifications of related neuraluting molecular mechanisms have not previously been
identified, changes in LTP and LTD in brain reward cir- circuits.
cuits have been reported, and changes in the levels of
PSD-95 are known to lead to bidirectional modulation of Glutamatergic Plasticity Associated
with Behavioral Sensitizationsynaptic plasticity (see below). Interestingly, adenylate
cyclase 1, Pin/Dlc-2, and PSD-95 are all located on chro- Generally, monoamines act as modulators of fast synap-
tic transmission such as glutamatergic neurotransmis-mosome 11 (equivalent to human chromosome 17). The
possible vulnerability of this chromosome to addictive sion. Our findings illustrate a profound modification of
glutamatergic synaptic plasticity, highlighted by en-drugs will require genetic linkage and gene associa-
tion studies. hanced cortico-accumbal LTP, as a consequence of
genetic or pharmacological perturbations of monoamineUnder our filtering criteria, we found a surprisingly low
number of genes that are consistently up- or downregu- systems. Methamphetamine sensitization of rats con-
verts corticostriatal LTD into LTP (Nishioku et al., 1999).lated 14 days after the 5 day cocaine administration
regimen. Among 36,000 genes/EST clusters profiled, Chronic cocaine administration elicits depressed AMPA
receptor-mediated synaptic currents accompanied byonly 27 genes (or 0.08%) showed consistent alteration
in the striatum of cocaine-treated mice. Moreover, no a reduced long-term depression (LTD) in the nucleus
accumbens (Thomas et al., 2001). Consistently, aftergene showed more than 2-fold changes relative to the
saline controls. Strikingly, however, 11 of the 27 genes chronic psychostimulant treatments, nucleus accum-
bens neurons become significantly less responsive to(40.7%) were also similarly affected in at least one of
the mutants, and 6 genes (22.2%) were affected in all glutamate (White et al., 1995). Taken together, drugs of
abuse may alter brain reward circuits by impairing thethe mutants. These data suggest that while a 14-day
withdrawal period has washed away many of the tran- bidirectional plasticity of excitatory synapses.
A PSD-95-mediated dual-role scheme can explain thesient transcriptional adaptations caused by chronic co-
caine, a significant portion of the remaining genes might multifaceted glutamatergic synaptic modifications fol-
lowing chronic drug administration. First, a host ofbe involved in core features of sensitization. The subtle
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receptors, ion channels, and signal transduction mole- of dopamine receptors (Fiorentini et al., 2003). Second,
glutamatergic and dopaminergic axons form a “synapticcules interacting with PSD-95 at the postsynaptic den-
triad” at postsynaptic dendritic spines in the striatum.sity might be involved in synaptic plasticity (Husi et al.,
This close spatial association may be required for the2000; Sheng and Kim, 2002). Genetic dissection of the
converging and coordinating actions of the two afferentNMDA receptor-PSD-95 signaling complex shows that
pathways. The altered postsynaptic architecture due topathways controlling the bidirectional modification of
the lack of PSD-95 may change the interplay of the twoglutamatergic synaptic strength are regulated by PSD-
systems, engaging the glutamate synapses to a state95 and its binding partners (Migaud et al., 1998; Komi-
more responsive to DA modulation. Aberrant DA-gluta-yama et al., 2002). A targeted disruption of PSD-95 fa-
mate interaction is implicated in a number of dopamine-vors induction of hippocampal LTP (Migaud et al., 1998).
related disorders, including schizophrenia (Mohn et al.,Second, PSD-95 may control the synaptic AMPA recep-
1999; Carlsson et al., 2001). The potential role of PSD-95tor number, and thus basal transmission, independent
in these brain disorders will require further investigation.of total available AMPA receptors (Schnell et al., 2002).
The failure to develop further sensitization to cocaineThe basal state and recent history of a synapse may
by PSD-95 null mice following repeated cocaine admin-influence its potential for undergoing subsequent plastic
istration highlights the indispensable role of PSD-95-medi-changes (Montgomery and Madison, 2002). Consis-
ated glutamatergic mechanisms in drug-dependent be-tently, expression of exogenous PSD-95 increases syn-
havioral plasticity. The loss of behavioral plasticity mightaptic AMPA receptors and occludes LTP and enhances
be expected, given the predisposed cocaine supersen-LTD in both the cortex (Beique and Andrade, 2003) and
sitivity in PSD-95 mutants. Lack of PSD-95 promoteshippocampus (Stein et al., 2003). If these two comple-
LTP and may also maximally facilitate the dopaminementary mechanisms hold in the basal ganglia as sug-
modulation of cortical glutamatergic input, effectivelygested by the enhanced cortico-accumbal LTP in the
uncoupling the glutamate system from additional dopa-PSD-95-GK mice, diminished PSD-95 levels could con-
mine system modulation. In this regard, the behavioraltribute to the observed decrease of basal glutamatergic
consequence of chronic drug exposure may be equiva-transmission and reduced LTD, as well as enhanced
lent to reducing glutamatergic PSD-95, which occludesLTP at cortico-accumbal synapses following repeated
sensitization. Regardless of the mechanism, our workcocaine administration. Further investigation of the
illustrates a molecular and cellular paradigm by whichNMDA and AMPA currents in the genetically modified
drugs of abuse can usurp the reward circuits throughmice using whole-cell patch-clamping will help dissect
altering the cortical glutamatergic system, leading tothe contribution of basal synaptic transmission and sig-
profound behavioral alterations in drug action.naling complexes/pathways to the enhanced LTP ob-
served in these mice.
Molecular and Cellular Mechanisms Underlying
Drug-Dependent Plasticity, Learning, and MemoryRole of PSD-95 and Glutamatergic Transmission
Persistent modification of synaptic strength, such asin Dopamine Signaling and Drug-Induced
LTP and LTD, has been considered a cellular mechanismBehavioral Plasticity
underlying learning and memory (Chen and Tonegawa,
Changes of both the dopamine and glutamate systems
1997; Kandel, 1997). Interestingly, half of the commonly
are implicated in drug-induced plasticity. While the con-
affected genes identified in our sensitization-based for-
tribution of dopaminergic transmission to behavioral ward genetic screen are also implicated in synaptic plas-
sensitization has been recognized, how plastic changes ticity and learning and memory. Adenylate cyclase I reg-
of the glutamatergic systems contribute to this process ulates synaptic efficacy (Zhong and Wu, 1991) and
remains elusive. The removal of PSD-95 in mice leads learning and memory in Drosophila (Livingstone et al.,
to two major behavioral manifestations. First, it aug- 1984) and hippocampus-dependent LTP and memory
ments the acute locomotor stimulating effect of cocaine, in mice (Wong et al., 1999). Nitric oxide and NOS activity
and second, it prevents the development of further regulate LTP and LTD in several brain regions and ap-
sensitization following chronic cocaine administration. pear essential in various memory tasks (reviewed in
These data suggest that the changes in PSD-95 levels Prast and Philippu, 2001). PSD-95 mutation leads to
elicited by repeated drug exposure must serve as a altered hippocampal LTP and impaired spatial learning
contributing mechanism that promotes behavioral sen- (Migaud et al., 1998), as well as altered striatal LTP
sitization. This contrasts with the compensatory mecha- and diminished drug-induced behavioral plasticity (this
nism in which some drug-induced neuroadaptations study). Together, our work provides direct support for
counteract the behavioral manifestation. For example, the notion that the molecular and cellular mechanisms
chronic cocaine administration induces Cdk5 (Bibb et underling the long-lasting behavioral plasticity associ-
al., 2001), which appears to serve a homeostatic re- ated with psychostimulant action may be similar to those
sponse to dampen sensitivity to subsequent stimulation. implicated in learning and memory (Berke and Hyman,
Two potential mechanisms could underlie the PSD- 2000; Nestler, 2001; Schultz, 2002), and more impor-
95 regulation of psychostimulant responsiveness. First, tantly, identifies specific molecules to support this con-
PSD-95 may directly or indirectly interact with subtypes tention. It is likely that in both cases, impairment of
of dopamine receptors and affects dopamine signaling. the bidirectional synaptic plasticity at related synapses
For example, PSD-95 modulates the internalization of might deteriorate the performance of related brain re-
NMDA receptors (Roche et al., 2001), which in turn may ward circuits, leading to abnormal experience-depen-
interact with dopamine receptors (Lee et al., 2002) and dent neural plasticity, including that induced by ad-
dictive drugs.influence the desensitization, trafficking, and signaling
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Experimental Procedures injection. All injections were performed i.p. Age-matched mice re-
ceived saline and served as controls.
Mice
All experiments were conducted in accordance with the National Brain Slices and Electrophysiology
Institutes of Health guidelines for the care and use of animals and Following deep isofluorene anesthesia, adult mice (3–5 month) were
with an approved animal protocol from the Duke University Animal quickly decapitated and the brain removed to ice-cold ACSF con-
Care and Use Committee. Generation of DAT/, NET/, and sisting of (in mM): 126 NaCl, 18 NaHCO3, 1.6 KCl, 1.2 NaH2PO4,
VMAT2/ was described previously (Giros et al., 1996; Wang et al., 2.5 CaCl2, 1.2 MgSO4, and 11 glucose, saturated with 95% O2/5%
1997; Xu et al., 2000). All three lines of genetically modified mice were CO2. Sagittal slices (200–400m) containing the nucleus accumbens
backcrossed at least ten generations on the C57BL/6J background. were prepared using a vibrotome and stored in ACSF at room tem-
Age-matched (3–5 month) C57BL/6J mice were used as controls to perature. Following recovery for at least 1 hr, slices were transferred
these three mutant strains. Detailed description of the generation to a recording chamber filled with constantly perfused (1.5–2 ml/
of PSD-95-GK mutant mice will be reported elsewhere (M.I.A. and min) ACSF saturated with 95% O2/5% CO2. Picrotoxin (100 M) was
S.G.N.G.). PSD-95 wt and GK littermates were used for the experi- included to block GABAA receptors in all experiments.
ments presented in Figures 6–8. Mice were housed at standard lab Extracellular field recordings were made at the nucleus accum-
conditions (12 hr light/dark cycle) with food and water provided bens with a glass micropipette filled with 1 M NaCl (5 M	). Signals
ad libitum. were amplified with an Axoclamp 2B at the BRIDGE mode. Stimuli were
delivered at 0.05 Hz with a bipolar stimulating electrode placed at
the prefrontal cortex (PFC) near the PFC-accumbens border 0.5–3 mmMicroarray Experiments
dorsal to the recording electrode. At the beginning of each experi-MIAME (minimal information about a microarray experiment)-com-
ment, the stimulus intensity was adjusted to evoke a half-maximalpliant format regarding experimental design, sample and probe
field response. fEPSP amplitude was defined as the average of thepreparation, hybridization procedures and parameters, data analy-
amplitude from the peak of the early positivity to the peak negativity,sis, and array design as defined in the guidelines established by
and the amplitude from the peak negativity to the peak late positivity.MGED (http://www.mged.org) is detailed in Supplemental Data at
LTP was induced by tetanus that consisted of 100 pulses at 100 Hzhttp://www.neuron.org/cgi/content/full/41/4/625/DC1.
at an intensity that induced maximum population spikes (approxi-
mately 1.5-fold of the test stimulus). Data were filtered at 3 kHz and
Real Time RT-PCR
digitized at 10 kHz using pCLAMP.
The procedure for real-time RT-PCR has been described previously
(Kim et al., 2002). One or two striatum per mouse were homogenized
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